These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
323 related articles for article (PubMed ID: 37526745)
1. A comparative study using insulin pump therapy and continuous glucose monitoring in newly diagnosed very young children with type 1 diabetes: it is possible to bend the curve of HbA1c. Castorani V; Favalli V; Rigamonti A; Frontino G; Di Tonno R; Morotti E; Sandullo F; Scialabba F; Arrigoni F; Dionisi B; Foglino R; Morosini C; Olivieri G; Barera G; Meschi F; Bonfanti R Acta Diabetol; 2023 Dec; 60(12):1719-1726. PubMed ID: 37526745 [TBL] [Abstract][Full Text] [Related]
2. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT. Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847 [TBL] [Abstract][Full Text] [Related]
3. Diabetes technology and treatments in the paediatric age group. Shalitin S; Peter Chase H Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816 [TBL] [Abstract][Full Text] [Related]
4. Does the timing of insulin pump therapy initiation after type 1 diabetes onset have an impact on glycemic control? Shalitin S; Lahav-Ritte T; Lebenthal Y; Devries L; Phillip M Diabetes Technol Ther; 2012 May; 14(5):389-97. PubMed ID: 22283639 [TBL] [Abstract][Full Text] [Related]
5. Glycemic Outcomes in Adults With T1D Are Impacted More by Continuous Glucose Monitoring Than by Insulin Delivery Method: 3 Years of Follow-Up From the COMISAIR Study. Šoupal J; Petruželková L; Grunberger G; Hásková A; Flekač M; Matoulek M; Mikeš O; Pelcl T; Škrha J; Horová E; Škrha J; Parkin CG; Svačina Š; Prázný M Diabetes Care; 2020 Jan; 43(1):37-43. PubMed ID: 31530663 [TBL] [Abstract][Full Text] [Related]
6. Factors associated with glycemic variability in children with type 1 diabetes mellitus based on flash glucose monitoring system. Zhang L; Guo K; Xu Y; Bai J; Ma Y; Fu L; Liu J; Hu K; Li X; Jiang H; Yang L Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 47(4):462-468. PubMed ID: 35545341 [TBL] [Abstract][Full Text] [Related]
7. Comparing the effectiveness of continuous subcutaneous insulin infusion with multiple daily insulin injection for patients with type 1 diabetes mellitus evaluated by retrospective continuous glucose monitoring: A real-world data analysis. Keyu G; Jiaqi L; Liyin Z; Jianan Y; Li F; Zhiyi D; Qin Z; Xia L; Lin Y; Zhiguang Z Front Public Health; 2022; 10():990281. PubMed ID: 36091534 [TBL] [Abstract][Full Text] [Related]
8. Glycemia Risk Index Assessment in a Pediatric and Adult Patient Cohort With Type 1 Diabetes Mellitus. Díaz-Soto G; Pérez-López P; Férnandez-Velasco P; Nieto de la Marca MO; Delgado E; Del Amo S; de Luis D; Bahillo-Curieses P J Diabetes Sci Technol; 2024 Sep; 18(5):1063-1069. PubMed ID: 36794818 [TBL] [Abstract][Full Text] [Related]
9. Comparison between a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) using continuous glucose monitoring in metabolically optimized type 1 diabetes patients: A randomized open-labelled parallel study. Ruiz-de-Adana MS; Dominguez-Lopez ME; Gonzalez-Molero I; Machado A; Martin V; Cardona I; de-la-Higuera M; Tapia MJ; Soriguer F; Anarte MT; Rojo-Martínez G Med Clin (Barc); 2016 Mar; 146(6):239-46. PubMed ID: 26656958 [TBL] [Abstract][Full Text] [Related]
10. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis. Yeh HC; Brown TT; Maruthur N; Ranasinghe P; Berger Z; Suh YD; Wilson LM; Haberl EB; Brick J; Bass EB; Golden SH Ann Intern Med; 2012 Sep; 157(5):336-47. PubMed ID: 22777524 [TBL] [Abstract][Full Text] [Related]
11. Three-variate trajectories of metabolic control, body mass index, and insulin dose: Heterogeneous response to initiation of pump therapy in youth with type 1 diabetes. Tauschmann M; Schwandt A; Prinz N; Becker M; Biester T; Hess M; Holder M; Karges B; Näke A; Kuss O; von Sengbusch S; Holl RW; Pediatr Diabetes; 2022 May; 23(3):330-340. PubMed ID: 35084795 [TBL] [Abstract][Full Text] [Related]
12. Insulin pump treatment; increasing prevalence, and predictors for better metabolic outcome in Danish children and adolescents with type 1 diabetes. Olsen B; Johannesen J; Fredheim S; Svensson J; Pediatr Diabetes; 2015 Jun; 16(4):256-62. PubMed ID: 25082292 [TBL] [Abstract][Full Text] [Related]
13. Impact of insulin pump therapy on long-term glycemic control in a pediatric Spanish cohort. Colino E; Martín-Frías M; Yelmo R; Álvarez MÁ; Roldán B; Barrio R Diabetes Res Clin Pract; 2016 Mar; 113():69-76. PubMed ID: 26972965 [TBL] [Abstract][Full Text] [Related]
14. Insulin pump therapy with and without continuous glucose monitoring in pregnant women with type 1 diabetes: a prospective observational Orchestra Foundation study in Poland. Cypryk K; Wender-Ozegowska E; Cyganek K; Sieradzki J; Skoczylas K; Chen X; Cordero TL; Shin J; Cohen O Acta Diabetol; 2023 Apr; 60(4):553-561. PubMed ID: 36653533 [TBL] [Abstract][Full Text] [Related]
15. Continuous subcutaneous insulin infusion and multiple dose of insulin regimen display similar patterns of blood glucose excursions in pediatric type 1 diabetes. Alemzadeh R; Palma-Sisto P; Parton EA; Holzum MK Diabetes Technol Ther; 2005 Aug; 7(4):587-96. PubMed ID: 16120030 [TBL] [Abstract][Full Text] [Related]
16. The Effects of Subcutaneous Insulin Infusion Versus Multiple Insulin Injections on Glucose Variability in Young Adults with Type 1 Diabetes: The 2-Year Follow-Up of the Observational METRO Study. Maiorino MI; Bellastella G; Casciano O; Cirillo P; Simeon V; Chiodini P; Petrizzo M; Gicchino M; Romano O; Caruso P; Giugliano D; Esposito K Diabetes Technol Ther; 2018 Feb; 20(2):117-126. PubMed ID: 29303370 [TBL] [Abstract][Full Text] [Related]
17. [Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes mellitus]. Hasselmann C; Bonnemaison E; Faure N; Mercat I; Bouillo Pépin-Donat M; Magontier N; Chantepie A; Labarthe F Arch Pediatr; 2012 Jun; 19(6):593-8. PubMed ID: 22584198 [TBL] [Abstract][Full Text] [Related]
18. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting. Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467 [TBL] [Abstract][Full Text] [Related]
19. Comparison between sensor-augmented insulin therapy with continuous subcutaneous insulin infusion or multiple daily injections in everyday life: 3-day analysis of glucose patterns and sensor accuracy in children. Zucchini S; Scipione M; Balsamo C; Maltoni G; Rollo A; Molinari E; Mangoni L; Cicognani A Diabetes Technol Ther; 2011 Dec; 13(12):1187-93. PubMed ID: 21854193 [TBL] [Abstract][Full Text] [Related]
20. Continuous subcutaneous insulin infusion versus multiple daily injection regimens in children and young people at diagnosis of type 1 diabetes: pragmatic randomised controlled trial and economic evaluation. Blair JC; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes DA; Gamble C; BMJ; 2019 Apr; 365():l1226. PubMed ID: 30944112 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]